• 한국식품영양과학회지
• /
• 제21권2호
• /
• pp.117-123
• /
• 1992

Nicotinamide의 항 당뇨작용을 연구할 목적으로 streptozotocin으로 당뇨병을 유발시킨 흰 쥐를 모델동물로 하여 수분섭취량과 체중, 혈당, 뇨당 및 혈중 in-sulin함량과 췌장중 효소변동을 형태학적인 측면과 함께 상호 비교 관찰하였다. Nicotinamide의 전처리로 STZ에 의해 유발되는 당뇨병시 나타나는 생리적 현상의 감소 및 혈당증가가 유의성있게 감소되었으며 혈중 insulin농도도 STZ에 의해 현저히 억제되던 것이 nice-tinamide의 전처리로 정상수준으로 회복되었다. 혈청중 lipase 및 trypsin활성은 STZ투여에 의해 증가되었으며, amylase활성은 대조군에 비해서 억제되었으나 nicotinamide의 전처리로 lipase, trypsin 및 amylase활성이 회복되었다. 췌장의 형태학적인 변화에서는 STZ 투여로 췌장소엽세포 및 췌관을 포함하는 외분비계의 조직에는 변화가 없으나 Langerhans's islet $\beta$세포가 심하게 파괴되었고 nicotinamide의 전처리로 $\beta$세포의 파괴가 현저하게 감소되었다.

• 대한치과교정학회지
• /
• 제53권6호
• /
• pp.393-401
• /
• 2023

Objective: To investigate the long-term effects of 4-hexylresorcinol (4HR) on facial skeletal growth in growing male rats, with a focus on diabetic animal models. Methods: Forty male rats were used. Of them, type 1 diabetes mellitus was induced in 20 animals by administering 40 mg/kg streptozotocin (STZ), and they were assigned to either the STZ or 4HR-injected group (STZ/4HR group). The remaining 20 healthy rats were divided into control and 4HR groups. We administered 4HR subcutaneously at a weekly dose of 10 mg/kg until the rats were euthanized. At 16 weeks of age, whole blood was collected, and microcomputed tomography of the skull and femur was performed. Results: All craniofacial linear measurements were smaller in the STZ group than in the control group. The mandibular molar width was significantly smaller in the 4HR group than in the control group (P = 0.031) but larger in the STZ/4HR group than in the STZ group (P = 0.011). Among the diabetic animals, the STZ/4HR group exhibited significantly greater cortical bone thickness, bone mineral density, and bone volume than the STZ group. Serum testosterone levels were also significantly higher in the STZ/4HR group than in the STZ group. Conclusions: 4HR administration may have divergent effects on mandibular growth and bone mass in healthy and diabetic rats. In the context of diabetes, 4HR appears to have beneficial effects, potentially through the modulation of mitochondrial respiration.

• Journal of Nutrition and Health
• /
• 제47권6호
• /
• pp.394-402
• /
• 2014

본 연구는 황칠나무의 부위별 추출물의 항당뇨효능을 평가하기 위해, 황칠나무의 잎과 줄기의 열수추출물과 에탄올추출물을 분리하여 항산화능과 당뇨질환 개선효능을 측정하였다. 그 결과, total polyphenol과 total flavonoid의 농도는 DLW에서 가장 높게 나타났으며, 다음으로 DLE, DSW, DSE 순서로 나타났다. 또한, DPPH 소거능은 DLW가 대부분의 농도에서 가장 높게 나타났으며, DLE는 $500{\mu}g/mL$의 농도에서 가장 높은 DPPH 소거능을 나타내었다. 항산화능이 우수한 DLW와 DLE를 선정하여 STZ로 유도된 당뇨모델동물에 2주간 투여하여 항당뇨 효능을 분석하였다. 그 결과, 체중은 STZ/vehicle 처리군이 급격히 감소하였으나 STZ/DLW와 STZ/DLE 처리군에서 서서히 감소하였다. 혈당량은 STZ/vehicle 처리군에서 급격히 증가하였으며, STZ/DLW 처리군과 STZ/DLE 처리군에서만 유의적인 감소를 나타내었다. 그러나, 혈청 내 인슐린의 농도는 STZ/vehicle 처리군에 비하여 STZ/DLW와 STZ/DLE 처리군에서 증가하였으며, 특히 STZ/DEL-200 처리군에서 가장 높은 농도를 나타내었다. 이러한 변화는 췌장의 조직학적 변화와 면역염색의 결과에서도 동일하게 관찰되었다. 더불어, 뇨당 농도는 STZ/vehicle 처리군에서 급격히 증가하였으며, 오직 STZ/DLW-200 처리군과 STZ/DLE-200 처리군에서만 유의적으로 감소하였다. 이러한 결과는 황칠나무의 잎의 열수추출물과 에탄올추출물은 우수한 항산화효능과 베타세포의 사멸을 억제함으로서 당뇨질환을 개선하는 효능이 있음을 제시하고 있으며, 특히, 200 mg/kg의 농도가 우수한 효능을 나타내는 농도임을 제시하고 있다.

• 한국식품영양과학회지
• /
• 제20권3호
• /
• pp.203-208
• /
• 1991

The present study was undertaken in order to elucidate the effects of pretreatment with nicotinamide on changes in the hepatic metabolizing enzyme system inducted by streptozotocin (STZ). In rats, STZ(50mg/kg) administered by tail vein caused a significant rise in hepatic aniline hydroxylase and a decrease in aminopyrine N-demethylase when compared to control (p<0.05). Pretreatment with nicotinamice inhibited these effects (p<0.05). Similarly, STZ induced changes in hepatic microsomal cytochrome P-450 activity were inhibited by pretreatment with nicotinamide (p<0.05). However, changes in UDP-glucuronyl transferase and sulfortransferase activity were not significantly different(p>0.05). Pretreatment with nicotinamide also prevented STZ induced increases in glutathion S-tranferase activity when compared to the control(p<0.05). There results suggest that nicotinamide pretreatment suppresses STZ-induced changes in the hepatic metabolizing enzyme system.

• Asian-Australasian Journal of Animal Sciences
• /
• 제24권6호
• /
• pp.818-824
• /
• 2011

Eight LW${\times}$D crossbred, castrated weanling piglets were used to examine the effect of hyperglycemia by streptozotocin (STZ)-injection on oxidative and anti-oxidative status in circulating fluid. Every two of the eight piglets were intravenously administrated STZ at a dose of 0 (control), 100, 125 or 150 mg/kg BW, respectively, and on 15th day after the STZ-injection, some markers of the oxidative stress in circulating fluid were measured to evaluate oxidative and anti-oxidative status in the piglets. First, piglets with hyperglycemia were selected from the STZ-injected piglets as measured by the levels of fasting plasma glucose (FPG) during 2 weeks after the STZ-injection. Additionally, data obtained from the intravenous glucose tolerance test (IVGTT) on 14th day were analyzed. Secondly, the data obtained in this experiment were divided into the control group and the hyperglycemic (STZ) group, and compared. The FPG level or area under curve (AUC) for plasma glucose during the IVGTT in the STZ-induced diabetic piglets was slightly significantly (FPG, p = 0.070; AUC, p = 0.072) higher compared with the control. On the other hand, the plasma level of lipid peroxidation in the STZ-induced diabetic piglets was significantly (p<0.05) higher compared with the control. These results raise the possibility that STZ-induced diabetic piglets produced in this study can be used as a diabetic animal model to research the pathogenic mechanisms or therapy of complications in diabetic mellitus.

• Nutritional Sciences
• /
• 제6권4호
• /
• pp.201-208
• /
• 2003

This research was conducted to study the effects of the supplementation of multi-extracts of mori folium (MF) and of exercise on plasma insulin and glucose levels in streptozotocin (STZ)-induced diabetic rats. Eight male Sprague-Dawley rats, 4 weeks old, were assigned to each experimental group and were raised in the laboratory for 10 weeks. The animal groups consisted of a normal-control group, a STZ-control group, 3 STZ-induced diabetic groups supplemented ad libitum with various amounts of MF extracts (MF-720, MF-360, and MF-180 groups), and a STZ-induced diabetic group supplemented with MF-360 along with exercise. In the normal-control group, glucose tolerance tests resulted in the peak blood glucose level being achieved in 15 minutes and a fasting blood glucose level being achieved in 60 minutes. In the STZ-control group, the peak blood glucose level was reached after 60 minutes and, even after 90 minutes, blood glucose shown at a significantly higher level compared to the fasting levels. In the groups supplemented with MF extracts, the blood glucose level peaked after 30 minutes of glucose challenge, and returned to the fasting level after 90 minutes; the MF-360 and MF-360+exercise groups showed the best levels of glucose tolerance. Blood glucose levels in the STZ-induced diabetic groups were significantly higher compared to the normal-control group. However, after 7 weeks of supplementation with MF extracts, a significant lowering of blood glucose levels was observed in all groups supplemented with the MF extract. The best effect was observed in the group given MF extract combined with exercise. Compared to the normal-control group, blood insulin levels were significantly lower in all STZ-induced diabetic groups; however, a significantly higher level of insulin was observed in the groups given MF extracts compared to the STZ-control group. This study shows that the supplementation of MF extracts in STZ-induced diabetic rats resulted in increased blood insulin levels and lower blood glucose levels.

• The Korean Journal of Physiology and Pharmacology
• /
• 제3권4호
• /
• pp.375-382
• /
• 1999

Growing evidence indicates that enhanced generation or actions of nitric oxide (NO) are implicated in the pathogenesis of hypertension in spontaneously hypertensive rats and diabetic nephropathy in streptozotocin (STZ)-induced diabetic rats. We investigated whether inducible nitric oxide synthase (iNOS) expression in STZ-induced diabetic rats is responsible for the alterations of vascular reactivity. Diabetic state was confirmed 28 days after injection of STZ (i.p) in rats by measuring blood glucose. In order to evaluate whether short term (4 weeks) diabetic state is related with altered vascular reactivity caused by iNOS expression, isometric tension experiments were performed. In addition, plasma nitrite/nitrate (NOx) levels and expression of iNOS in the lung and aorta of control and STZ-treated rats were compared by using Griess reagent and Western analysis, respectively. Results indicated that STZ-treated rats increased the maximal contractile response of the aorta to phenylephrine (PE), and high $K^+,$ while the sensitivity remained unaltered. Endothelium-dependent relaxation, but not SNP-mediated relaxation, was reduced in STZ-treated rats. Plasma nitrite/nitrates are significantly increased in STZ-treated rats compared to controls. The malondialdehyde (MDA) contents of liver, serum, and aorta of diabetic rats were also significantly increased. Furthermore, nitrotyrosine, a specific foot print of peroxynitrite, was significantly increased in endothelial cells and smooth muscle layers in STZ-induced diabetic aorta. Taken together, the present findings indicate that enhanced release of NO by iNOS along with increased lipid peroxidation in diabetic conditions may be responsible, at least in part, for the augmented contractility, possibly through the modification of endothelial integrity or ecNOS activity of endothelium in STZ-diabetic rat aorta.

• 생명과학회지
• /
• 제20권5호
• /
• pp.691-696
• /
• 2010

본 연구에서는 STZ로 당뇨병이 유발된 흰쥐의 간, 신장, 췌장 조직으로부터 소당탕(SDT)의 항산화 효과를 확인하여 다음과 같은 결과를 얻었다. 1. SDT의 투여는 간, 신장, 췌장 내 항산화효소인 SOD의 활성을 유의적으로 증가시켰다. 2. SDT의 투여는 간, 신장, 췌장 내 항산화물질인 GSH의 농도를 유의적으로 증가시켰다. 3. SDT의 투여는 간, 신장, 췌장 내 지질과산화 산물인 MDA의 농도를 유의적으로 감소시켰다. 이상의 결과로 볼 때 소당탕은 STZ로 유발된 당뇨병 흰쥐에서 항산화효소 활성과 항산화물질 생성을 증가시키고, 산화물질 생성을 억제함으로써 항산화 효과가 확인되었다.

• Biomolecules & Therapeutics
• /
• 제5권3호
• /
• pp.253-259
• /
• 1997

The effect of corticosteroid on the diabetic pregnant rats and their fetuses was investigated. Streptozotocin (STB) was injected into the pregnant rats on the fifth day of pregnancy. Dexamethasone (DXM) was injected into the pregnant rats on the 17th, 18th, 19th and 20th days of pregnancy In prenatal rats, the body weight, an abortion rate, number of fetus, the ratio of lecithin/sphingomyelin (L/S) and the levels of blood glucose and phosphatidylglycerol (PG) were determined. In the postnatal rats, the body weight, the levels of blood glucose, fetal number, stillbirth rate, an organ weight and the levels of hepatic glycogen, protein and triglyceride were determined. The body weight of fetuses was lower in the DXM group and higher in the STZ group than the those of control group. Blood glucose of fetuses produced hypoglycemia in the STZ group compared with the control group. A significant increase in the abortion and stillbirth rates was observed in STZ group. The levels of glycogen, protein and triglyceride in fetus liver and the weight of pancreas were significantly increased in the 572 and STZ+DXM groups compared with the control group. The L/S ratio and the level of PG in the amniotic (quid were significantly decreased in STZ group compared with the control group, whereas those of the STZ+DXM group were similar to the control group. It has been observed that corticosteroid administration on the STZ-induced diabetic rats during final stage of pregnancy can prevent the respiratory depression syndrome of neonatal rats.

• Journal of Nutrition and Health
• /
• 제36권10호
• /
• pp.981-989
• /
• 2003

The hypoglycemic effects of four edible plants (Angelicae tenuissimae (A. ten.), Pleurospermum kamtschaticum (P. kam.), Adenophora remotiflora (A. rem.) and Zanthoxylum schinifolium (Z. sch.)) in streptozotocin (STZ) -induced diabetic rats were investigated. Sprague-Dawley male rats weighing 190-230 g were induced diabetes mellitus by the STZ injection (45 mg/kg) into the tail vein and were divided into six groups ; normal, STZ-control and four edible plant groups (A. ten., P kam., A. rem. and Z. sch. groups). Normal and STZ-control groups were fed a AIN-93 diet and four groups of STZ-induced diabetic rats were fed one of each experimental diets containing 10％ of the edible plant powder for 4 weeks. Diabetic rats showed the lower weight gain compared to the normal rats. In experimental groups except P. kam., AST activities were close to normal. A. ten. group were lowered ALT activities slightly. The plasma glucose levels of the diabetic experimental groups were significantly decreased at 4th week. The plasma insulin levels in diabetic experimental groups were not significantly different compared to the STZ-control group. The liver glycogen levels in STZ injected rats were significantly lower in compared to the normal rats. However no significant differences were found in response experimental plants intake in diabetic rats. The muscle glycogen were not significantly different among all the groups.